Carlyle Group INC Form 4 insider transactions

Director Lawton W. Fitt was granted 4,450 restricted stock units as part of The Carlyle Group Inc. equity incentive plan.

Director Derica W. Rice acquired 7,383 shares of Carlyle Group Inc. common stock through restricted stock unit awards.

Director Afsaneh Beschloss was granted 4,450 restricted stock units by The Carlyle Group Inc. as part of an equity incentive plan.

Carlyle Group Director David M. Rubenstein reported the sale of 500,000 shares for $23.3 million and a charitable donation of 100,000 shares.

Carlyle Group entities converted over 9 million Medline Holdings LP Common Units into Medline Inc. Class A Common Stock across two transactions in early March 2026.

Carlyle Group CFO Justin Plouffe reported the withholding of 46,176 shares for tax obligations related to a restricted stock unit award vesting.

Carlyle Group's General Counsel, Jeffrey W. Ferguson, reported a tax-related withholding of 937 common shares following a restricted stock unit award vesting.

Carlyle Group's Chief Accounting Officer, Charles E. Andrews Jr., reported a disposition of 6,354 shares for tax withholding related to restricted stock unit vesting.

Carlyle Group Co-President Mark Jenkins reported a tax-related disposition of 46,176 common shares following a restricted stock unit award vesting.

Carlyle Group Co-President John C. Redett reported a tax-related withholding of 86,781 common shares at $55.41 per share, retaining 1,848,312 shares.

Carlyle Group Co-President Jeffrey Nedelman's Form 4 filing details the withholding of shares for tax obligations related to a restricted stock unit award vesting.

Carlyle Group's Chief Operating Officer, Lindsay LoBue, had 75,033 shares withheld for tax obligations related to restricted stock unit vesting.

Carlyle Group Co-President Mark Jenkins reported significant restricted stock unit awards and tax-related share withholdings, increasing his beneficial ownership.

Carlyle Group Co-President Jeffrey Nedelman reported new restricted stock unit awards and shares withheld for tax obligations.

Carlyle Group Co-President John C. Redett reported significant equity transactions, including tax-related share withholding and new restricted stock unit awards.

Carlyle Group's Chief Accounting Officer, Charles E. Andrews Jr., reported acquiring 23,240 restricted stock units, increasing his beneficial ownership to 153,330 shares.

Carlyle Group's Chief Operating Officer, Lindsay LoBue, reported the acquisition of over 127,000 restricted stock units and the withholding of shares for tax purposes.

Carlyle Group CEO Harvey M. Schwartz had 578,862 shares withheld by the company for tax obligations related to a restricted stock unit award vesting.

Carlyle Group's General Counsel, Jeffrey W. Ferguson, reported an increase in his beneficial ownership of common stock through restricted stock unit awards, alongside shares withheld for tax purposes.

Carlyle Group's CFO, Justin Plouffe, reported the acquisition of 50,474 restricted stock units and the withholding of 2,792 shares for tax purposes.

Carlyle Group Inc. reported internal transfers of Medline Inc. Class A and Class B Common Stock and Common Units to affiliated entities for no consideration.

Carlyle Group Inc. reported significant changes in its beneficial ownership of Medline Inc. Class A and Class B common stock, including a major sale and conversions.

Carlyle Group Inc.'s Chief Operating Officer, Lindsay LoBue, was granted 183,655 restricted stock units, subject to performance and time-based vesting conditions.

Carlyle Group Inc.'s Chief Financial Officer, John C. Redett, was granted 550,965 restricted stock units, increasing his beneficial ownership to 1,651,081 shares.

Carlyle Group CEO Harvey M. Schwartz reported the withholding of 310,696 common shares for tax obligations related to a restricted stock unit award vesting, maintaining his beneficial ownership.

Carlyle Group Director David M. Rubenstein reported a charitable donation and a sale of 625,000 shares of common stock each, executed on December 10, 2025, under a 10b5-1 plan.

Carlyle Group Director Anthony Welters reported a planned charitable donation of 12,906 common shares, set to occur on November 25, 2025, reducing his beneficial ownership to 43,399 shares.

Carlyle Group Inc. CEO Harvey M. Schwartz accrued 28,519 shares of common stock as dividend equivalent units on November 19, 2025.

Carlyle Group Inc.'s Chief Financial Officer, John C. Redett, acquired 3,730 shares of common stock through dividend equivalent units tied to existing restricted stock awards.

Carlyle Group's Chief Operating Officer, Lindsay LoBue, accrued 620 dividend equivalent units tied to existing restricted stock unit awards.